In patients with left ventricular failure and reduced ejection fractions, the risk of LV thrombus formation and systemic arterial embolization appears to be primarily in patients who are in atrial fibrillation or who have large recent (within 3-6 months) myocardial infarctions. These groups and patients with a history of embolism should be anticoagulated.